[1]
I. Rodríguez-Barrios, R. Cid, y J. Infante, «In vivo testing of safety and immunogenicity of new vaccine candidates against PCV2 designed for a better performance than that showed by currently marketed vaccines», Bs, n.º 9, abr. 2020.